• Board of Directors

    • Mike McBrierty, Biogen, Board Chairman
    • Tom Adams, Pairwise Plants
    • Gray Armstrong, Pfizer
    • Chuck Blatchley, Grifols
    • Christopher Capel, Smith Anderson
    • David Chapin, Forma Life Science Marketing
    • Matthew Cooke, Davis Moore Capital
    • Bill Edwards, Merz North America
    • Mike Elder, Novozymes
    • Tom Fagley, Hughes Pittman & Gupton
    • Ed Field, BioLabs North Carolina
    • Neal Fowler, Liquidia Technologies
    • Maeve Gardner, GlaxoSmithKline
    • Mike Garrett, TCG
    • Alex Graham, Patheon/Thermo Fisher
    • Mark Harbaugh, Bioventus
    • Erica Jackson, K&L Gates
    • Christof Jensen, UCB
    • Matt Keffer, PricewaterhouseCoopers
    • Scott Kohne, BASF 
    • Ted Lithgow, Humacyte
    • Sheila Mikhail, Asklepios BioPharmaceutical
    • Kyle Rasbach, Pappas Capital
    • Russ Read, National Center for Biotechnology Workforce
    • Scott Sewell, Cook Medical
    • Giles Shih, BioResource International
    • Gary Shope, Patheon
    • Thomas Staab, BioCryst Pharmaceuticals
    • Blake Stevens, Alexandria Real Estate Equities
    • Susan Thomason, IQVIA
    • Rich West, Baebies
    • Tim Willis, MED1 Ventures 
    • Peter Wirth, RTI International
    • Adam Zerda, BD (Becton, Dickinson & Co.)

    ‚Äč